261 related articles for article (PubMed ID: 12359857)
1. Molecular imaging and biological evaluation of HuMV833 anti-VEGF antibody: implications for trial design of antiangiogenic antibodies.
Jayson GC; Zweit J; Jackson A; Mulatero C; Julyan P; Ranson M; Broughton L; Wagstaff J; Hakannson L; Groenewegen G; Bailey J; Smith N; Hastings D; Lawrance J; Haroon H; Ward T; McGown AT; Tang M; Levitt D; Marreaud S; Lehmann FF; Herold M; Zwierzina H;
J Natl Cancer Inst; 2002 Oct; 94(19):1484-93. PubMed ID: 12359857
[TBL] [Abstract][Full Text] [Related]
2. Preclinical pharmacokinetics, interspecies scaling, and tissue distribution of a humanized monoclonal antibody against vascular endothelial growth factor.
Lin YS; Nguyen C; Mendoza JL; Escandon E; Fei D; Meng YG; Modi NB
J Pharmacol Exp Ther; 1999 Jan; 288(1):371-8. PubMed ID: 9862791
[TBL] [Abstract][Full Text] [Related]
3. Wide spectrum of antitumor activity of a neutralizing monoclonal antibody to human vascular endothelial growth factor.
Asano M; Yukita A; Suzuki H
Jpn J Cancer Res; 1999 Jan; 90(1):93-100. PubMed ID: 10076571
[TBL] [Abstract][Full Text] [Related]
4. An anti-human VEGF monoclonal antibody, MV833, that exhibits potent anti-tumor activity in vivo.
Asano M; Yukita A; Matsumoto T; Hanatani M; Suzuki H
Hybridoma; 1998 Apr; 17(2):185-90. PubMed ID: 9627059
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor121.
Asano M; Yukita A; Matsumoto T; Kondo S; Suzuki H
Cancer Res; 1995 Nov; 55(22):5296-301. PubMed ID: 7585591
[TBL] [Abstract][Full Text] [Related]
6. Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer.
Gordon MS; Margolin K; Talpaz M; Sledge GW; Holmgren E; Benjamin R; Stalter S; Shak S; Adelman D
J Clin Oncol; 2001 Feb; 19(3):843-50. PubMed ID: 11157038
[TBL] [Abstract][Full Text] [Related]
7. The development of [(124)I]iodinated-VG76e: a novel tracer for imaging vascular endothelial growth factor in vivo using positron emission tomography.
Collingridge DR; Carroll VA; Glaser M; Aboagye EO; Osman S; Hutchinson OC; Barthel H; Luthra SK; Brady F; Bicknell R; Price P; Harris AL
Cancer Res; 2002 Oct; 62(20):5912-9. PubMed ID: 12384557
[TBL] [Abstract][Full Text] [Related]
8. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody.
Yuan F; Chen Y; Dellian M; Safabakhsh N; Ferrara N; Jain RK
Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14765-70. PubMed ID: 8962129
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice.
Brekken RA; Overholser JP; Stastny VA; Waltenberger J; Minna JD; Thorpe PE
Cancer Res; 2000 Sep; 60(18):5117-24. PubMed ID: 11016638
[TBL] [Abstract][Full Text] [Related]
10. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS
Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702
[TBL] [Abstract][Full Text] [Related]
11. Antibody to vascular endothelial growth factor slows growth of an androgen-independent xenograft model of prostate cancer.
Fox WD; Higgins B; Maiese KM; Drobnjak M; Cordon-Cardo C; Scher HI; Agus DB
Clin Cancer Res; 2002 Oct; 8(10):3226-31. PubMed ID: 12374693
[TBL] [Abstract][Full Text] [Related]
12. Tumor angiogenesis and accessibility: role of vascular endothelial growth factor.
Jain RK
Semin Oncol; 2002 Dec; 29(6 Suppl 16):3-9. PubMed ID: 12516032
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and concentration-response of murine anti-VEGF monoclonal antibody in tumor-bearing mice and extrapolation to humans.
Mordenti J; Thomsen K; Licko V; Chen H; Meng YG; Ferrara N
Toxicol Pathol; 1999; 27(1):14-21. PubMed ID: 10367667
[TBL] [Abstract][Full Text] [Related]
14. Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.
Lee CG; Heijn M; di Tomaso E; Griffon-Etienne G; Ancukiewicz M; Koike C; Park KR; Ferrara N; Jain RK; Suit HD; Boucher Y
Cancer Res; 2000 Oct; 60(19):5565-70. PubMed ID: 11034104
[TBL] [Abstract][Full Text] [Related]
15. VEGF-mediated angiogenesis of human pheochromocytomas is associated to malignancy and inhibited by anti-VEGF antibodies in experimental tumors.
Zielke A; Middeke M; Hoffmann S; Colombo-Benkmann M; Barth P; Hassan I; Wunderlich A; Hofbauer LC; Duh QY
Surgery; 2002 Dec; 132(6):1056-63; discussion 1063. PubMed ID: 12490855
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor and vascular targeting of solid tumors.
Brekken RA; Thorpe PE
Anticancer Res; 2001; 21(6B):4221-9. PubMed ID: 11908675
[TBL] [Abstract][Full Text] [Related]
17. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis.
Warren RS; Yuan H; Matli MR; Gillett NA; Ferrara N
J Clin Invest; 1995 Apr; 95(4):1789-97. PubMed ID: 7535799
[TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.
Ciardiello F; Bianco R; Damiano V; Fontanini G; Caputo R; Pomatico G; De Placido S; Bianco AR; Mendelsohn J; Tortora G
Clin Cancer Res; 2000 Sep; 6(9):3739-47. PubMed ID: 10999768
[TBL] [Abstract][Full Text] [Related]
19. Phase I investigation of recombinant anti-human vascular endothelial growth factor antibody in patients with advanced cancer.
Jayson GC; Mulatero C; Ranson M; Zweit J; Jackson A; Broughton L; Wagstaff J; Hakansson L; Groenewegen G; Lawrance J; Tang M; Wauk L; Levitt D; Marreaud S; Lehmann FF; Herold M; Zwierzina H;
Eur J Cancer; 2005 Mar; 41(4):555-63. PubMed ID: 15737560
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor and anti-metastatic effects of human-vascular-endothelial-growth-factor-neutralizing antibody on human colon and gastric carcinoma xenotransplanted orthotopically into nude mice.
Kanai T; Konno H; Tanaka T; Baba M; Matsumoto K; Nakamura S; Yukita A; Asano M; Suzuki H; Baba S
Int J Cancer; 1998 Sep; 77(6):933-6. PubMed ID: 9714067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
